This training program aims to produce a new generation of scientists, engineers and medical practitioners who are trained to possess the knowledge and skills to integrate innovations in nanotechnology and physical sciences to cancer diagnosis and treatment. Due to the complexity of cancer disease, there has been limited progress made in the field during the past few decades. It has become clear that the involvement of nano science and technology in oncology may fundamentally change our ways to diagnose and treat this lethal disease. We realized, however, that there is a serious lack of researchers who are competent of pursuing these highly interdisciplinary activities, and that the progress made in nanomedicine during the past decade depends mostly on researchers'tremendous effort in expanding their knowledge to the related areas beyond their expertise when the needs arise. We believe that by preparing our students and postdoctoral fellows for knowledge and skills in this emerging field in the early stages of their career development, we would be able to significantly expedite such endeavor in the next few years. To this extent, we have carefully assembled an interdisciplinary preceptor team consisting of 40 faculty members of different backgrounds and whose research interests are in the interdisciplinary areas between oncology, engineering, and physical sciences in six departments at University of Washington (UW) and Fred Hutchinson Cancer Research Center (FHCRC). This unique blend expertise, combined with a carefully designed curriculum, will expose trainees to an excellent combination of fundamental as well as clinically-oriented cancer research. The major components of our training activities include: 1) laboratory or clinical research in which each trainee will be co-advised by at least two faculty members, one from medical background and one from science or engineering;2) participation in a required and an elective graduate course;3) attendance in seminar programs and a clinical tumor board;4) presentations in annual symposium by students on their research progress;5) a set of enrichment activities including a journal club, and training on ethic conduct and leadership skills;6) frequent feedback from faculty to trainees and annual progress evaluation from an executive committee. We request support for 2 predoctoral students, 5 postdoctoral and 2 MD fellows every year in the duration of the program with each trainee receiving a two-year support. The participating institutions and faculty of this program have strong records in recruitment of underrepresented minorities. The training program will work with existing programs at the both institutes and make additional program specific efforts to recruit minority trainees.

Public Health Relevance

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA138312-05
Application #
8540829
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
2009-09-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2013
Total Cost
$394,466
Indirect Cost
$26,742
Name
University of Washington
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hayamizu, Yuhei; So, Christopher R; Dag, Sefa et al. (2016) Bioelectronic interfaces by spontaneously organized peptides on 2D atomic single layer materials. Sci Rep 6:33778
Li, Junwei; Zrazhevskiy, Pavel; Gao, Xiaohu (2016) Eliminating Size-Associated Diffusion Constraints for Rapid On-Surface Bioassays with Nanoparticle Probes. Small 12:1035-43
Stephen, Zachary R; Dayringer, Christopher J; Lim, Josh J et al. (2016) Approach to Rapid Synthesis and Functionalization of Iron Oxide Nanoparticles for High Gene Transfection. ACS Appl Mater Interfaces 8:6320-8
Wang, Kui; Kievit, Forrest M; Sham, Jonathan G et al. (2016) Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. Small 12:477-87
Mu, Qingxin; Lin, Guanyou; Patton, Victoria K et al. (2016) Gemcitabine and Chlorotoxin Conjugated Iron Oxide Nanoparticles for Glioblastoma Therapy. J Mater Chem B Mater Biol Med 4:32-36
Chang, Fei-Chien; Tsao, Ching-Ting; Lin, Anqi et al. (2016) PEG-chitosan hydrogel with tunable stiffness for study of drug response of breast cancer cells. Polymers (Basel) 8:
Jana, Soumen; Levengood, Sheeny K Lan; Zhang, Miqin (2016) Anisotropic Materials for Skeletal-Muscle-Tissue Engineering. Adv Mater :
Zrazhevskiy, Pavel; Akilesh, Shreeram; Tai, Wanyi et al. (2016) Cross-Platform DNA Encoding for Single-Cell Imaging of Gene Expression. Angew Chem Int Ed Engl 55:8975-8
Mu, Qingxin; Kievit, Forrest M; Kant, Rajeev J et al. (2015) Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells. Nanoscale 7:18010-4
Johnson, Eleanor S; Anand, Robbyn K; Chiu, Daniel T (2015) Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen. Anal Chem 87:9389-95

Showing the most recent 10 out of 93 publications